Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3674884 | 0.95 | CA12 (0.30) | CA12CA1CA2CA7CA13 | |
| SCHEMBL31126249 | 0.95 | CA12 (0.30) | CA12CA1CA2CA7CA13 | |
| Lithium SCHEMBL1555897 | 0.95 | CA12 (0.30) | CA12CA1CA2CA7CA13 | |
| SCHEMBL438137 | 0.95 | CA1 (0.32) | CA12CA1CA2CA7CA13 | |
| SCHEMBL1378109 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL8639732 | 0.90 | — | — | |
| SCHEMBL435632 | 0.90 | CA12 (0.32) | CA12CA1CA2CA7CA13 | |
| SCHEMBL3945315 | 0.88 | — | — | |
| SCHEMBL1100490 | 0.84 | — | — | |
| SCHEMBL7875154 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1404 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116053577-B | Polyurea and polythiourea super-ion solid electrolyte and preparation method and application thereof | 华南理工大学 | 2026-05-12 | — | — | CN | claimed |
| US-20260015369-A1 | PEROVSKITE SYSTEM INCLUDING ANILINIUM-BASED LIGANDS AND RELATED PEROVSKITE SOLAR CELL | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2026-01-15 | — | — | US | claimed |
| CN-120040764-A | Polynorbornene imide insulating material and preparation method and application thereof | 哈尔滨理工大学 | 2025-05-27 | — | — | CN | claimed |
| CN-119899141-A | Chiral pentafluorophenyl urea compound and preparation method and application thereof | 沈阳化工大学 | 2025-04-29 | — | — | CN | claimed |
| CN-119798252-A | Method for preparing N-ortho-acyl substituted nitrogen-containing heterocyclic compound and amine-shrinking iron (II) complex thereof | 中国石油化工股份有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119406727-A | Gas diffusion layer with hydrophilic and hydrophobic transmission channels and preparation method thereof | 武汉理工大学 | 2025-02-11 | — | — | CN | claimed |
| CN-116622119-B | Perylene-containing polyarylether-based super-hydrophobic radiation cooling film with layered structure and preparation method thereof | 哈尔滨工业大学 | 2025-01-14 | — | — | CN | claimed |
| CN-118290733-B | Polyimide with high fluorine content, gas separation membrane, and preparation method and application thereof | 大连理工大学 | 2024-08-30 | — | — | CN | claimed |
| CN-118290733-A | Polyimide with high fluorine content, gas separation membrane, and preparation method and application thereof | 大连理工大学 | 2024-07-05 | — | — | CN | claimed |
| CN-118183708-A | Method for preparing fluorocarbon material by using fluorine-containing polymer | 重庆大学锂电及新材料遂宁研究院 | 2024-06-14 | — | — | CN | claimed |
| EP-1062040-A1 | OLEFIN POLYMERISATION CATALYST BASED ON METALLOCENE COMPLEXES AND PERFLUORINATED OLIGOARYL DERIVATIVES OF ALUMINATES | ExxonMobil Oil Corporation (US) | 2000-12-27 | — | — | EP | claimed |
| US-6153550-A | Olefin polymerization catalyst based on metallocene complexes and perfluorinated oligoaryl derivatives of aluminates | MOBILE OIL CORPORATION (US) | 2000-11-28 | — | — | US | claimed |
| US-6150360-A | ADMINISTERING TO A PATIENT SUFFERING FROM HUMAN IMMUNODEFICIENCY VIRUS INFECTION A TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVE | JANSSEN PHARMACEUTICA N.V. (BE) | 2000-11-21 | — | — | US | claimed |
| US-6100213-A | Aluminum compound-containing solid catalyst component, catalyst for olefin polymerization and method for producing olefin polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-08-08 | — | — | US | claimed |
| WO-1999050256-A1 | TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS | JANSSEN PHARMACEUTICA N.V. (BE) | 1999-10-07 | — | — | WO | claimed |
| WO-1999030819-A1 | OLEFIN POLYMERISATION CATALYST BASED ON METALLOCENE COMPLEXES AND PERFLUORINATED OLIGOARYL DERIVATIVES OF ALUMINATES | MOBIL OIL CORPORATION (US) | 1999-06-24 | — | — | WO | claimed |
| EP-0893985-A1 | KERATIN FIBRE DYE COMPOSITIONS CONTAINING IMIDAZOLO-AZOLE COMPOUNDS, USE THEREOF AS DYE COUPLERS, AND DYEING METHOD | L'OREAL (FR) | 1999-02-03 | — | — | EP | claimed |
| WO-1997035552-A1 | KERATIN FIBRE DYE COMPOSITIONS CONTAINING IMIDAZOLO-AZOLE COMPOUNDS, USE THEREOF AS DYE COUPLERS, AND DYEING METHOD | L'OREAL (FR) | 1997-10-02 | — | — | WO | claimed |
| US-4350674-A | VISUALIZING HEPTOBILIARY SYSTEM | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-09-21 | — | — | US | claimed |
| EP-0019790-A2 | Technetium-99m labeled acetanilidoiminodiacetates for liver function diagnosis and process for their preparation | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-12-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015369-A1 | PEROVSKITE SYSTEM INCLUDING ANILINIUM-BASED LIGANDS AND RELATED PEROVSKITE SOLAR CELL | BMX, ITGB3, TSNAX | CA12 273/4885CA1 730/4885CA2 224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.